Genetic and biased agonist-mediated reductions in ß-arrestin recruitment prolong cAMP signaling at glucagon family receptors. (2021)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1074/jbc.ra120.016334
PubMed Identifier: 33268378
Publication URI: http://europepmc.org/abstract/MED/33268378
Type: Journal Article/Review
Volume: 296
Parent Publication: The Journal of biological chemistry
ISSN: 0021-9258